Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.19262DOI Listing

Publication Analysis

Top Keywords

macrophage activation
4
activation syndrome
4
syndrome granulocyte
4
granulocyte colony-stimulating
4
colony-stimulating factor
4
factor patient
4
patient systemic
4
systemic lupus
4
lupus erythematosus
4
macrophage
1

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Mayo Clinic, Jacksonville, FL, USA.

Background: Selective corticolimbic vulnerability to tau pathology in Alzheimer's disease (AD) underlies clinicopathologic heterogeneity. The goal of this presentation will be to examine spatial heterogeneity of tangle distribution on a continuum through the utility of the corticolimbic index (CLix).

Method: We will discuss the development of CLix in the Florida Autopsied Multi-Ethnic (FLAME) cohort, which sought to collapse the spatial distribution of thioflavin-S tangle counts in AD (n=1361) to assign a continuum: hippocampal sparing with cortical predominance (<10), representative/typical (≥10 to <30), and limbic predominant with cortical sparing (≥30).

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

cheonan chungmu hospital, cheonan si, Korea, Republic of (South).

Background: Vascular contributions to dementia & Alzheimer's disease are increasing recognized. Recent studies have suggested that blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction, including the early clinical stages of AD. Apolipoprotein E4(APOE4), the major AD susceptibility gene, leads to accelerated blood-brain barrier breakdown & degeneration of brain capillary pericyte that maintain blood-brain barrier integrity.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China.

Background: Microglia play a critical role in the pathogenesis and development of Alzheimer's disease (AD). Selective small-molecule colony-stimulating factor 1 receptors (CSF1R) inhibitor, designed to deplete microglia, could be used to meliorate AD. This study aimed to investigate the effects and mechanisms of chimeric antigen receptor T (CAR-T) cells targeting CSF1R in 6-month-old APP/PS1 male mice.

View Article and Find Full Text PDF

Background: Oxylipins are oxygenated fatty acid (FA) metabolites that are important mediators of inflammation. Neuroinflammation is a hallmark of Alzheimer's disease (AD), and brains of AD patients contain more pro-inflammatory and less anti-inflammatory oxylipins compared to healthy controls. Free fatty acid receptor 4 (Ffar4) is a G-protein coupled receptor for medium and long-chain FAs, including, but not limited to, omega-3-polyunsaturated FAs.

View Article and Find Full Text PDF

Background: SHIP1 is a phosphatidyl inositol phosphatase encoded by INPP5D, which has been identified as a risk gene for Alzheimer's disease (AD). SHIP1 is expressed in microglia, the resident macrophage in brain. It is a complex, multidomain protein that acts as a negative regulator downstream from TREM2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!